TNFRSF1B and Alzheimer disease: Indeed, in further support of the importance to preserve TNFR2 signaling in AD, it was shown that statins reduced progression of AD in clinical trials or even prevented the onset of it [374,375], and lovastatin established this by increasing TNFR2 expression.